Human JC polyomavirus (JCV) is the etiologic agent of the neurodegenerative disease progressive multifocal leukoencephalopathy. By using JCV as a model, we investigated the role of the viral early protein tumor antigen (TAg) in the binding of two cellular proteins, Pura and YB-1, to JCV regulatory sequences. Results from band-shift assays with purified YB-1, Purca, and TAg indicated that efficient binding of Pura, a strong activator ofearly gene transcription, to a single-stranded target sequence corresponding to the viral lytic control element, is diminished in the presence of the late gene activator YB-1, which recognizes the opposite strand of the Pura binding site. Of particular interest was the ability of Pura and TAg to enhance binding ofYB-1 to DNA molecules without being associated with this complex. Binding studies using a mutant peptide encompassing the N terminus ofYB-1 indicated that the C terminus ofYB-1 is important for its DNA binding activity. The ability of Purax and TAg to increase binding ofYB-1 to DNA is independent ofthe YB-1 C terminus. Similarly, results from band-shift assays using Pura variants indicated that two distinct regions of this protein contribute either to its ability to bind DNA or to its ability to enhance YB-1 DNA binding activity. Based on the interaction of Pura, YB-1, and TAg, and their binding to DNA, a model is proposed for the role of these proteins in transcription ofviral early and late genes during the lytic cycle.
binding ofYB-1 to DNA is independent ofthe YB-1 C terminus. Similarly, results from band-shift assays using Pura variants indicated that two distinct regions of this protein contribute either to its ability to bind DNA or to its ability to enhance YB-1 DNA binding activity. Based on the interaction of Pura, YB-1, and TAg, and their binding to DNA, a model is proposed for the role of these proteins in transcription ofviral early and late genes during the lytic cycle.
to cell-specific transcriptional factors, other regulatory proteins found in various cells and tissues are believed to be critical in facilitating viral gene expression during the lytic cycle (13) (14) (15) (16) (17) (18) . Results from this (10-12, 17, 19) and other (9, 20) laboratories have indicated that the 98-bp enhancer/promoter sequence of JCV encompasses multiple cis-regulatory elements that interact specifically with nuclear proteins and modulate viral early and late gene transcription. A region designated the lytic control element (LCE) in the 98-bp repeat proximal to the origin of DNA replication contains a pentanucleotide repeat sequence, AGGGAAGGGA, juxtaposed to a poly(dT-dA) tract that displays a single-stranded configuration (21) . This motif differentially affects viral gene expression by positively and negatively modulating early and late promoter transcription (17, 19) and plays an important role in viral DNA replication (22, 23) . In this study we demonstrate that two distinct cellular proteins, Pura and YB-1, activators for the early and late gene transcription of JCV, respectively, modulate each other's binding to the LCE. Moreover, we show that the viral early protein TAg is capable of enhancing binding of YB-1 to DNA molecules. We propose a working model for the potential role of LCE-binding proteins and the viral TAg in programming the early-to-late shift of the viral gene transcription during the lytic cycle.
Studies of the small DNA tumor viruses have provided insights into a number of regulatory pathways used in the synthesis and processing of eukaryotic mRNA. In particular, work on papovaviruses including simian virus 40 (SV40) has led to the identification of several regulatory factors that modulate transcription of eukaryotic genes (1, 2) . This group of viruses utilizes the host cell machinery to promote viral transcription bidirectionally during lytic infection, leading to the production of regulatory tumor antigen (TAg) and structural capsid proteins at early and late phases of infection, respectively (3, 4) . Accumulation of TAg at the early phase of infection is critical for the transcriptional switch from early to late promoters and the progression of subsequent events during the lytic cycle, including DNA replication in permissive cells (3, 4) .
The human JC polyomavirus (JCV) replicates efficiently in glial cells and has been repeatedly isolated from demyelinated plaques within the brain of patients with progressive multifocal leukoencephalopathy, a neurodegenerative disease (for reviews, see refs. 5-7). Several studies have established that the restricted host range of JCV to glial cells is determined at the level of viral gene transcription that is mediated by glialenriched DNA-binding regulatory proteins (8) (9) (10) (11) (12) . In addition
MATERIALS AND METHODS
Expression and Purification of Pura and YB-1 from Bacteria. Maltose-binding protein (MBP)-Pura and MBP-YB-1 fusion proteins were produced in bacteria using the plasmids pMAL-Pura and pMAL-YB-1, respectively. The expressor plasmids were constructed by inserting cDNA sequences for Pura (24) and YB-1 (25) in-frame into pMAL-cR1 vectors. Proteins were expressed in Escherichia coli and purified on amylose affinity columns (New England Biolabs). Pura deletion mutants were expressed as glutathione S-transferase fusion proteins in E. coli BL21 Lys.S and purified with glutathione-agarose (Sigma) (26 
1087
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. nica nuclear polyhedrosis virus, AcMNPV. The recombinant baculovirus 941T that expresses the SV40 TAg was a gift from M. Summers (Texas A&M University) and R. Lanford (Southwest Foundation for Biomedical Research). To prepare purified JCV and SV40 TAgs, Sf9 insect cells were infected with B-JCT or 941T virus and lysed 48 h later. Viral proteins were purified by binding to immunoaffinity columns containing monoclonal antibody PAb2000 (anti-JCV TAg) or PAb9O1 (anti-SV40 TAg) and eluting with triethylamine buffer containing 20 mM triethylamine (pH 11.3), 10% glycerol, and leupeptin (10 ,g/ml).
Band-Shift Assay. Binding reactions with purified MBP-YB-1 and MBP-Pura were performed in 12 mM Hepes, pH 7.9/4 mM Tris HCl, pH 7.5/60 mM KCl/5 mM MgCl2/0.8 mM dithiothreitol/0.5 jig of poly(dI-dC). DNA-protein complexes were allowed to form during a 20-to 30-min incubation of the protein sample with 50,000 cpm of probe DNA on ice.
Reaction products were analyzed on a 9% polyacrylamide/ 0.5 x TBE gel (27) and detected by autoradiography. Binding activities were quantified by laser densitometry of autoradiograms.
RESULTS
Interaction of YB-1 and Purax with LCE. The pentanucleotide repeat sequence of LCE (Fig. 1A) is a potential target for the binding of Pura, a single-stranded DNA-binding protein that exhibits specific affinity for a purine-rich sequence element present in several gene flanking regions and origins of DNA replication (24, 28) . Pura preferentially binds to closely spaced repeats of the triplet GGN. The cDNA encoding Pura was cloned into a prokaryotic expression system (pMAL-cR), and the bacterially expressed Pura protein exhibits binding affinity to the pentanucleotide repeat located on the late strand of the LCE (PL), but not to that on the early strand (PE)-Pura also binds, although weakly, to the duplex LCE (PEL) (Fig. 1B) .
By using the DNA fragment derived from the central region of the JCV 98-bp repeat as a probe, we isolated a recombinant YB-1 clone with the ability to bind to a C + T-rich sequence of LCE (D.A.K., C.F.C., N.N.C., G.L.G., G. Raj, B. Schwartz, and K.K., unpublished data). YB-1 is a member of a large family of DNA-binding proteins that was initially isolated from a human B-cell expression library by its capacity to interact with the Y-box region found in class II major histocompatibility complex genes (25) . Evidently, YB-1 plays a role in transcriptional activity of genes containing a Y box and may influence transport of the nascent RNAs from nuclei to cytoplasm (for review, see ref. 29) . The bacterially produced YB-1 protein showed an affinity to the early strand of the LCE (PE) and, like Pura, had a reduced ability for association with the double-stranded PEL probe (Fig. 1B) . Addition of Pura to the YB-1 binding reaction mixture increased the intensity of the band corresponding to the YB-1-PE complex (Fig. 2A4) or the YB-i-PEL complex (Fig. 2C , lanes 1-3) in vitro. Even under these conditions, Pura did not interact with PE, either alone or complexed with YB-1. Apparently, Pura enhances YB-1 binding to its target sequence without direct interaction with the DNA molecule. Addition of YB-1 to the Pura binding reaction mixture diminished formation of the Pura-PL complex (Fig.   2B ). Again, YB-1 showed a similar inability to interact with the PL sequence either directly or indirectly through Pura. Furthermore, YB-1 inhibited the binding of Pura to the PEL probe (Fig. 2C, lanes 5-7) . These observations indicate that crosscommunication between the cellular proteins YB-1 and Pura determines their association with an important regulatory sequence of JCV; this may determine their regulatory function on the viral genome.
Stimulation of YB- TAg, the viral early protein, is crucial for the regulation of early and late promoter activities (30, 31) . Apparently, SV40 TAg exerts its regulatory function indirectly through cellular intermediary factor(s). In our initial studies to evaluate the possible effect of JCV TAg on binding of YB-1 and Pura to their respective targets in the viral LCE, we found that a purified baculovirus-produced JCV TAg (B.B., P. M. MacKeen, and R.J.F., unpublished data) has no binding activity to the single-or double-stranded LCE sequences in the absence or presence of the LCE binding proteins, including Pura and YB-1. Interestingly, the JCV TAg, like Pura, did enhance binding of YB-1 to its single-stranded (PE) and doublestranded (PEL) target sequence (Fig. 3A, lanes 2 and 3) . Addition of an optimal amount of Pura to this reaction showed no further enhancement of the binding activity of YB-1 to PE or PEL DNAs (Fig. 3A, compare lanes 3 and 4) . Inclusion of JCV TAg in a reaction mixture containing Pura and PL resulted in no significant alteration in the intensity of the band corresponding to the Pura-PL complex (Fig. 14 (Fig. 3B) . However, in the presence of YB-1, SV40 TAg showed minor, if any, inhibitory activity on Pura binding to the pentanucleotide repeat sequence (Fig. 3B , probe L, compare lanes 5 and 8 with lanes 4, 7, and 9). Competition experiments using unlabeled PE DNA revealed that preincubation of YB-1 with TAg or Pura drastically increased the stability of the YB-1-PE complex (Fig. 4) double-stranded PEL probes were incubated with YB-1 (300 ng), Pura (600 ng), and JCV TAg (100 ng) in the combinations indicated. Probes were used in large excess (3 X 105 cpm per lane) in each reaction mixture to ensure detection of all possible complexes. No major bands other than those corresponding to the DNA-protein complexes were detected. (B) SV40 TAg (100 ng) was mixed with Pura and YB-1 as described in A, and the complexes were resolved by band-shift assay.
The reciprocal experiment using Pura and PL probe indicated that preincubation of Pura with YB-1 had no effect on the stability of Pura-PL complex. These data describe an activity Identification of the Regions Within YB-1 and Pura That Are Important for Their DNA-Binding Activities. YB-1 is a member of an emerging family of DNA-binding proteins that share common structural motifs, including the highly conserved 80-amino acid cold-shock domain (CSD) at the N terminus, a central arginine/proline-rich domain, and alternating acidic domains at the C terminus (Fig. 5A) . To identify the region(s) of YB-1 that determines its binding to the PE and its perturbation of the Pura-PL interaction, a mutant variant of YB-1 possessing the N terminus of the protein (HF-1) was used in the band-shift DNA-binding experiment. Like YB-1, mutant HF-1 formed a complex, designated Y, with PE and PEL DNA but not with PL DNA (Fig. SB, lane 2) . Furthermore, HF-1 decreased, in trans, binding of Pura to its target pentanucleotide repeat sequence (Fig. SB, compare lanes 3 and 4) . Unlike YB-1, association of HF-1 and PE was not increased upon addition of TAg and Pura at optimum concentrations (Fig. SB, compare lane 5 with lanes 6 and 8) . Both the DNA-binding activity of HF-1 and its inhibitory action on Pura DNA binding remained unchanged upon the addition of JCV TAg (Fig. SB) . These observations suggest that the N terminus of YB-1, which includes CSD, is sufficient for its ability to bind DNA and to inhibit the Pura DNA-binding activity. These data also indicate that the C terminus of YB-1 is important for Pura and JCV TAg to exert their positive action on YB-1 DNAbinding activity.
In analogous studies, the importance of various regions of Pura in binding to DNA and stimulating the binding of YB-1 to its target sequence was evaluated by using a series of purified bacterially produced peptides encompassing various regions of Pura (Fig. 6) . Structurally, Pura has several interesting features, including three 23-amino acid repeats separated by two 26-amino acid repeats thought to be important for its DNA-binding activity (28) . The N terminus of Pura is highly glycine-rich, whereas the C terminus includes a region of a potential amphipathic helix. A classical Pro-Glu-Ser-Thr (PEST) domain in the central region of Pura is believed to accelerate its turnover in cells (33) . Experiments to evaluate the ability of Pura variants (2B, 3B, NR, SR, 200, BN, 100, and B) to interact with the PL probe (Fig. 6 ) indicated that the central region of Pura, spanning amino acids 65-191 present in the B peptide, is sufficient for its interaction with the PL probe. Note that Pura variants containing the N and/or C terminus potentiated YB-1 interaction with the PE probe, whereas the B variant, which encompasses the Pura central region but not the N and C terminus, was unable to stimulate YB-1 DNA-binding activity. These observations differentiate between at least two distinct domains of Pura: a domain located between amino acids 65 and 274 that is essential for DNA binding and two domains, one from amino acids 1 to 85 and one from amino acids 274 and 322 that are essential for facilitating binding of YB-1 to its target DNA sequence.
DISCUSSION
The data presented here demonstrate that the cellular proteins YB-1 and Pura differentially modulate their reciprocal binding to the respective single-and double-stranded target sequences. YB-1 augments its own binding to PE and PEL at the expense of Pura binding to the PL in what appears to involve two distinct interactions: one is mediated by the N terminus of YB-1 and reduces binding of Pura to its DNA target and the other requires the C terminus of YB-1 and the glycine-or glutamine-rich domain of Pura, which increases YB-1 binding to the DNA. The enhancement in binding is unlikely to involve any topological modifications in the target DNA, given the small size of the pentanucleotide probes (15 nt). It should be noted that in addition to the LCE, PUR elements are also present in the origin of the JCV DNA replication. Recent studies in this laboratory have shown that the ori-PUR element mediates activation of the JCVL promoter by the human immunodeficiency virus 1 Tat protein in glial cells (34) . It is conceivable that interaction of Pura and Tat and their cooperation may influence JCV gene regulation. Our present studies indicate that cellular proteins Pura and YB-1 mediate a broad spectrum of activities regulating viral life cycle.
These observations are likely to have a functional significance in regulation of viral gene expression. Recent preliminary results in our laboratory indicate that Pura is a potent activator of early gene transcription (N.N.C. and K.K., unpublished data), whereas YB-1 is a weak enhancer of early gene transcription that more effectively stimulates viral late gene transcription in glial cells (D.A.K., et al, unpublished data). Therefore, intercommunication between YB-1 and Pura, which influences their interaction with the JCV regulatory sequences, may be an important determinant for TAg synthesis at the early phase of infection. Perhaps it should be noted that some JCV isolates contain a 23-bp insert in the LCE motif that provides a potential target for binding of G+C-rich binding protein(s) (15) . Future characterization of protein(s) that bind to the 23-bp insert, and their interaction with YB-1 and Pura in the presence and absence of TAg should shed a light on the cooperative interaction of these regulatory proteins with the JCV control sequence.
The ability of two unrelated proteins, the cellular Pura and the viral TAg, to exert similar effects on the binding of YB-1 to DNA is intriguing, both mechanistically and functionally. It is possible that a shift occurs in the binding of YB-1 to its target DNA during the course of the viral lytic cycle. According to this model, YB-1 may have poor affinity for the viral DNA early in the lytic cycle. At this stage, binding of Pura to its target PL, which is facilitated by the single-stranded configuration displayed by the LCE (21), enhances expression of the early genes and assists YB-1 in binding to the early strand of LCE. In the late phase of the viral lytic cycle, viral TAg increases the interaction of YB-1 with DNA and, thereby, stimulates late gene transcription, removes Pura from the viral DNA, and hence, suppresses early gene expression. Such a model of the interplay between Pura and YB-1 in the absence and the presence of TAg is reminiscent of the early and late phases of the viral lytic cycle. Thus the interaction of these two cellular proteins with the viral antigen could be an important determinant for the transition of the early-to-late cycle of infection and for the transactivation of the JCV late promoter.
